Clinical Trial Update: Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Neuroendocrine Tumors [Phase 1, Phase 2]

View source ↗

Summary

Perspective Therapeutics is recruiting for a Phase 1/Phase 2 study of targeted alpha-particle therapy for advanced SSTR2-positive neuroendocrine tumors. The tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchial Neuroendocrine Tumor
• Gastroenteropancreatic Neuroendocrine Tumor
• Neuroendocrine Tumor
• Paraganglioma
• Pheochromocytoma

Snippet

Sponsor: Perspective Therapeutics | Conditions: Neuroendocrine Tumors Unresectable, Neuroendocrine Tumor Metastatic | Phase 1, Phase 2 | Status: RECRUITING